FDA approved the first injectable treatment for the virus. Morris Singletary’s physician is switching him from daily pills to these monthly injections.
This is a development that many of those living with HIV might not have imagined would ever come.Singletary lives in Atlanta.
He posted to his Facebook last week about ending daily tablets.“Today is my last day taking pills for HIV!!! 15 years ago l was taking 23 pills.
CABENUVA (cabotegravir; rilpivirine) here I come.”Cabenuva is a two-shot combo from the pharmaceutical company, Viiv Healthcare, which is owned by GlaxoSmithKline.Cabenuva consists of two injections: rilpivirine, commonly sold as Edurant by Janssen, and a new drug, Cabotegravir, from ViiV Healthcare.